# Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death

> **NCT05446779** · — · ACTIVE_NOT_RECRUITING · sponsor: **Helsinki University Central Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Primary Aldosteronism
- Adrenal Cushing Syndrome
- Pheochromocytoma
- Endocrine Neoplasia

## Interventions

- **DIAGNOSTIC_TEST:** Adrenal aldosterone synthase (CYP11B2) staining
- **DIAGNOSTIC_TEST:** Adrenal cortisol synthase (CYP11B1) staining
- **DIAGNOSTIC_TEST:** Histopathological analysis

## Key facts

- **NCT ID:** NCT05446779
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-02-03
- **Primary completion:** 2023-01-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-04-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05446779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05446779, "Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05446779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*